State Street’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-6,509,988
| Closed | -$302M | – | 3864 |
|
|
2019
Q2 | $302M | Sell |
6,509,988
-769,932
| -11% | -$21.6M | 0.02% | 576 |
|
|
2019
Q1 | $177M | Buy |
7,279,920
+23,186
| +0.3% | +$483K | 0.01% | 719 |
|
|
2018
Q4 | $103M | Sell |
7,256,734
-1,677,702
| -19% | -$25.4M | 0.01% | 889 |
|
|
2018
Q3 | $136M | Buy |
8,934,436
+1,253,175
| +16% | +$19.2M | 0.01% | 885 |
|
|
2018
Q2 | $129M | Sell |
7,681,261
-293,433
| -4% | -$4.67M | 0.01% | 881 |
|
|
2018
Q1 | $130M | Sell |
7,974,694
-1,330,140
| -14% | -$21.3M | 0.01% | 856 |
|
|
2017
Q4 | $119M | Buy |
9,304,834
+1,852,419
| +25% | +$21.1M | 0.01% | 930 |
|
|
2017
Q3 | $91.7M | Sell |
7,452,415
-2,092,110
| -22% | -$19.4M | 0.01% | 1026 |
|
|
2017
Q2 | $79.9M | Buy |
9,544,525
+1,279,750
| +15% | +$10.5M | 0.01% | 1079 |
|
|
2017
Q1 | $73.9M | Buy |
8,264,775
+1,837,047
| +29% | +$19.5M | 0.01% | 1101 |
|
|
2016
Q4 | $56.5M | Buy |
6,427,728
+1,883,249
| +41% | +$13.9M | 0.01% | 1202 |
|
|
2016
Q3 | $30.7M | Buy |
4,544,479
+981,150
| +28% | +$3.79M | ﹤0.01% | 1491 |
|
|
2016
Q2 | $12.7M | Sell |
3,563,329
-1,249,335
| -26% | -$4.07M | ﹤0.01% | 2082 |
|
|
2016
Q1 | $14.2M | Buy |
4,812,664
+3,626
| +0.1% | +$10.9K | ﹤0.01% | 1955 |
|
|
2015
Q4 | $20.3M | Sell |
4,809,038
-1,652,294
| -26% | -$7.54M | ﹤0.01% | 1705 |
|
|
2015
Q3 | $29.5M | Buy |
6,461,332
+808,255
| +14% | +$4.79M | ﹤0.01% | 1491 |
|
|
2015
Q2 | $40.8M | Buy |
5,653,077
+781,466
| +16% | +$5.77M | ﹤0.01% | 1384 |
|
|
2015
Q1 | $35.9M | Buy |
4,871,611
+30,107
| +0.6% | +$214K | ﹤0.01% | 1438 |
|
|
2014
Q4 | $22.9M | Sell |
4,841,504
-1,492,433
| -24% | -$5.9M | ﹤0.01% | 1709 |
|
|
2014
Q3 | $22.6M | Buy |
6,333,937
+1,073,536
| +20% | +$4.23M | ﹤0.01% | 1652 |
|
|
2014
Q2 | $24M | Sell |
5,260,401
-255,994
| -5% | -$1.06M | ﹤0.01% | 1690 |
|
|
2014
Q1 | $25.9M | Buy |
5,516,395
+606,854
| +12% | +$3.05M | ﹤0.01% | 1579 |
|
|
2013
Q4 | $24.6M | Sell |
4,909,541
-380,129
| -7% | -$2.07M | ﹤0.01% | 1597 |
|
|
2013
Q3 | $32.9M | Buy |
5,289,670
+1,235,331
| +30% | +$7.34M | ﹤0.01% | 1397 |
|
|
2013
Q2 | $18.4M | Buy |
+4,054,339
| New | +$21.8M | ﹤0.01% | 1675 |
|
Other funds holding ARRY
State Street's ARRY Position: Q3 2019 in Review
State Street sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,509,988 shares — an estimated $302M sold.
State Street first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $302M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- State Street reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- State Street sold 6,509,988 Array Biopharma Inc shares in Q3 2019, an estimated $302M.
- State Street first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- State Street's Array Biopharma Inc position peaked at $302M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on State Street's 13F filing for Q3 2019, filed 14 Nov 2019.